Link (Oxford Academic) Rushworth GF, Megson IL
A study of nearly 28,000 23andMe users who reported taking GLP-1 weight-loss medications, published in Nature, found that a mutation in GLP1R, the gene encoding the protein targeted by GLP-1 drugs, was modestly but significantly associated with greater weight loss
In a week-long series , I-Team 8 dug into the benefits and costs associated with these medications
Unlike injections, the medication is available in pill form
GLP-1 use during early pregnancy may not increase risk of major adverse outcomes Taking GLP-1s during the first trimester of pregnancy does not appear to substantially increase the risk of adverse outcomes, according to a new study led by Harvard T.H
Staying organized keeps your bonuses cleaner and more effective